Smiths Medical Launches Innovative Solution for Better Pain Management

April 23, 2012

CADD®-Solis system now combines PCA and Programmed Intermittent Bolus (PIB) deliveries to labor analgesia and post-operative pain management

St. Paul, Minn., April 23, 2012 -- Smiths Medical, a leading global medical device manufacturer, announced today it has launched the CADD®-Solis pain management system version 3.0 with Programmed Intermittent Bolus (PIB) delivery in countries outside the United States. The new customizable system will help healthcare providers overcome challenges in maintaining effective epidural analgesia for labor and delivery or post-operative pain management patients.

Epidural analgesia has traditionally been provided to patients by manual bolus injections from a clinician, continuous infusions from an IV bag or intermittent infusions controlled by the patient. These techniques may result in inconsistent and ineffective pain relief, as well as frequent clinician interventions. PIB medication delivery consists of programmed intermittent boluses that can be supplemented by patient-controlled doses. Clinical studies show that PIB medication delivery provides better distribution of medication in the epidural space that helps improve patient satisfaction, decrease drug use and reduce clinician interventions. 

“The CADD®-Solis system version 3.0 with PIB combines intermittent boluses and patient-controlled doses in an integrated, innovative delivery solution,” said Tommy Johns, Vice President Global Product Management. “The PIB programming parameters and the delivery pressure performance provided by the CADD®-Solis system offer flexible drug delivery and reliable distribution of medication, which can help overcome some of the challenges associated with effective epidural analgesia.”

The CADD®-Solis ambulatory infusion system is a state-of-the-art pain management system that meets industry recognized standards for advanced error-reduction features in PCA pumps. The CADD®-Solis pump and CADD™-Solis medication safety software promote patient safety, patient care, and future scalable connectivity that is designed to grow with evolving clinical and technology needs. The platform is designed for nurses, anesthesiologists, pharmacists and other hospital personnel involved in pain management infusion therapy who want the confidence of knowing they are delivering the highest level of patient care, with the most advanced combination of SMART medication delivery safety, mobility, versatility and reliability.

CADD®-Solis Pain Management System Components: 

CADD®-Solis Ambulatory Infusion Pump – a small and lightweight pump that promotes patient mobility and clinician convenience. The versatile pump can be used for a variety of pain management therapies and patients.  Its large color graphic display screen helps clinicians view and verify pump programs, identify and respond to alarms and interpret therapy trends and patient activity. The pump’s task-based software and cell-phone design is familiar to users, promoting usability and safety. The scalable platform is designed to satisfy hospital’s current and future clinical requirements and health information technology initiatives.

CADD™-Solis Medication Safety Software - Administrator – designed to help reduce the risk of medication delivery errors, the Administrator software allows pharmacists to enter and store custom therapy-based protocols, drug names, concentrations and dosing limits for standardized programming downloads to CADD®-Solis pumps. 

CADD™ Medication Cassette Reservoirs and CADD® Administration Sets – exclusive reservoirs and sets contain or connect to medication and fit securely onto CADD®-Solis pumps to promote increased medication security. The pump with reservoirs can fit easily into a pouch so patients can be mobile during therapy.

About Smiths Medical

Smiths Medical is a leading supplier of specialized medical devices and equipment for global markets, focusing on the medication delivery, vital care and safety devices market segments.  It is part of Smiths Group, a global leader in applying advanced technologies for markets in threat and contraband detection, energy, medical devices, communications and engineered components.  Smiths Group employs around 22,000 people in more than 50 countries.

Media Contact:
Marysharon Owens
Director, Global Digital & Branding Strategy